Clearmind Medicine Inc. (CMND)
NASDAQ: CMND · Real-Time Price · USD
1.830
-0.110 (-5.67%)
At close: Sep 1, 2026, 4:00 PM EDT
1.820
-0.010 (-0.55%)
Pre-market: Sep 2, 2026, 6:01 AM EDT
Clearmind Medicine Market Cap
Clearmind Medicine has a market cap or net worth of $2.72 million as of September 2, 2026. Its market cap has decreased by -49.81% in one year.
Market Cap
2.72M
Enterprise Value
-10.79M
1-Year Change
-49.81%
Ranking
Category
Stock Price
$1.83
ChartMarket Cap Chart
Since August 16, 2021, Clearmind Medicine's market cap has decreased from $26.11M to $2.72M, a decrease of -89.59%. That is a compound annual growth rate of -36.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 2.72M | 0.15% |
| Dec 31, 2025 | 2.71M | -55.12% |
| Dec 31, 2024 | 6.05M | 27.16% |
| Dec 29, 2023 | 4.76M | -39.11% |
| Dec 30, 2022 | 7.81M | -59.09% |
| Dec 27, 2021 | 19.09M | -26.88% |
| Aug 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Calidi Biotherapeutics | 3.48M |
| Galmed Pharmaceuticals | 3.40M |
| Artelo Biosciences | 3.25M |
| Valion Bio | 3.17M |
| Curis | 3.11M |
| Propanc Biopharma | 3.08M |
| Genprex | 3.04M |
| Matinas BioPharma Holdings | 2.90M |